Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Burst Diagnostics engages in the future of at-home and point-of-care testing.
Co-Diagnostics is a molecular diagnostics company that enhances the output of molecular diagnostic tests.
CND Life Sciences is a medical technology company that develops evidence-based tool to assist physicians in diagnosing synucleinopathy.
RIVANNA commercializes ultrasound technologies that reduce the patient risk caused by radiation from X-ray-based medical imaging.
Juniper Biomedical is a neuromodulation MedTech company that is dramatically improving therapy for patients with pelvic health conditions.
TransCode Therapeutics is an RNA oncology company that develops and commercializes drugs for the treatment of metastatic cancer.
Neuronoff is a medical device developing comapny.
Averto Medical is a medical device manufacturing company.
RevBio was started with one goal in mind—to end medicine’s 50-year search for a biocompatible bone adhesive.
A digital health platform that uses analysis of eye-movements as a biomarker to assess brain health across neurological disorders.
Psilera is a biotechnology company that develops treatments for neurological and psychiatric disorders.
POP Biotechnologies LLC is Buffalo NY biotechnology company.
Regenerative Medical Solutions is a biotechnology company developing regenerative medical products used to treat diabetes.
CytoAgents is a biotechnology company focused on the the treatment of COVID-19, Influenza, and other viral infectious diseases.
BetterAge provides a personalized, web-based program to help individuals improve health and well-being.
Redefining Sample Preparation, Revolutionizing Genomics
TruDiagnostic is a biodata research company that offers epigenetic testing and research services.
Immuto Scientific is a biotechnology services company that provides analytical insights to pharmaceutical companies for drug discovery.
RealSeq Biosciences’ core expertise includes innovative proprietary technologies for bias-free small RNA/miRNA NGS library construction.
Vast Therapeutics is an innovative, preclinical-stage pharmaceutical company .
Lucid Diagnostics develops a non-invasive, office based diagnostic test for biomarkers to esophageal cancer.
Aavogen is a biotech startup that develops gene therapeutics for muscle wasting diseases.
Lactiga is a biotherapeutics company advancing its patented biologics to transform the anti-infective sector and protect vulnerable patients
PediaMetrix brings AI and computer vision to pediatric health to lower cost and improve outcome.
National Institutes of Health has invested in 491 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
National Institutes of Health's top investment sectors include Biotechnology, Health Care, Medical Device, Life Science, Medical. The firm invests across 25 different industry categories.
Among tracked funding rounds, LUCID DIAGNOSTICS INC. received $26.9M in a Post Ipo Equity round. National Institutes of Health's total known invested capital is $2.5B.
National Institutes of Health's average investment size is $5.9M across its portfolio of 491 companies.
Recent National Institutes of Health portfolio additions include Burst Diagnostics, Co-Diagnostics, CND Life Sciences, RIVANNA, Juniper Biomedical. These companies were founded in 2020 or later.